Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck(Universitätsklinikum Aachen), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Alexander Wehr(Universitätsklinikum Aachen), Felix Heymann(Universitätsklinikum Aachen), Dirk Eulberg(Noxxon Pharma (Germany)), Sebastian Huss(University Hospital Münster), Mihael Vucur(Düsseldorf University Hospital), Karlin Raja Karlmark(Universitätsklinikum Aachen), Tom Luedde(Heinrich Heine University Düsseldorf), Sven Klußmann(Aptar (Germany)), Nikolaus Gaßler(Ernst Abbe University of Applied Sciences Jena)
Cited by 608
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786